文献速递冠心病心力衰竭与心肌病

无症状心肌梗死与长期心力衰竭风险:ARIC研究

Silent Myocardial Infarction and Long-Term Risk of Heart Failure: The ARIC Study.
PubMed 文献 · J Am Coll Cardiol · 2018-01-01

中位随访13.0年发生976例HF事件,调整后SMI(HR 1.35)和CMI(HR 2.85)均与HF风险增加相关,且SMI在较年轻者中风险更强。

要点

  • SMI与HF风险增加独立相关(HR 1.35),但低于CMI(HR 2.85)。
  • SMI患者HF风险在低于中位年龄53岁人群中更强(HR 1.66)。
  • 需研究将SMI筛查纳入HF风险评估的成本效益及预防治疗。

核心结论

  • SMI与心力衰竭风险增加相关,但风险低于CMI。
  • 未来需研究SMI筛查作为HF风险评估部分的成本效益及预防治疗。

研究设计与样本

  • ARIC前瞻性队列研究,纳入9243名基线无心血管疾病参与者。
  • SMI定义为基线至第4次随访间心电图提示MI无CMI;HF事件从第4次随访至2010年。

主要发现

  • 第1至4次随访间发生305例SMI和331例CMI。
  • 第4次随访后中位随访13.0年发生976例HF事件。
  • HF发生率(每1000人年):CMI 30.4、SMI 16.2、无MI 7.8(p<0.001)。
  • 调整人口学和HF危险因素后,SMI的HR 1.35(95%CI 1.02-1.78),CMI的HR 2.85(95%CI 2.31-3.51)。
  • SMI与HF风险在低于中位年龄53岁者中更强(HR 1.66;95%CI 1.00-2.75 vs HR 1.19;95%CI 0.85-1.66;交互p<0.001)。

临床怎么用

  • 临床中应关注SMI患者的心力衰竭风险,尤其年轻患者。
  • SMI可作为HF风险评估的潜在考虑因素,但筛查成本效益待研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although silent myocardial infarction (SMI) accounts for about one-half of the total number of myocardial infarctions (MIs), the risk of heart failure (HF) among patients with SMI is not well established. OBJECTIVES: The purpose of this study was to examine the association of SMI and clinically manifested myocardial infarction (CMI) with HF, as compared with patients with no MI. METHODS: This analysis included 9,243 participants from the ARIC (Atherosclerosis Risk In Communities) study who were free of cardiovascular disease at baseline (ARIC visit 1: 1987 to 1989). SMI was defined as electrocardiographic evidence of MI without CMI after the baseline until ARIC visit 4 (1996 to 1998). HF events were ascertained starting from ARIC visit 4 until 2010 in individuals free of HF before that visit. RESULTS: Between ARIC visits 1 and 4, 305 SMIs and 331 CMIs occurred. After ARIC visit 4 and during a median follow-up of 13.0 years, 976 HF events occurred. The incidence rate of HF was higher in both CMI and SMI participants than in those without MI (incidence rates per 1,000 person-years were 30.4, 16.2, and 7.8, respectively; p < 0.001). In a model adjusted for demographics and HF risk factors, both SMI (hazard ratio [HR]: 1.35; 95% confidence interval [CI]: 1.02 to 1.78) and CMI (HR: 2.85; 95% CI: 2.31 to 3.51) were associated with increased risk of HF compared with no MI. These associations were consistent in subgroups of participants stratified by several HF risk predictors. However, the risk of HF associated with SMI was stronger in those younger than the median age (53 years) (HR: 1.66; 95% CI: 1.00 to 2.75 vs. HR: 1.19; 95% CI: 0.85 to 1.66, respectively; overall interaction p by MI type <0.001). CONCLUSIONS: SMI is associated with an increased risk of HF. Future research is needed to examine the cost effectiveness of screening for SMI as part of HF risk assessment, and to identify preventive therapies to improve the risk of HF among patients with SMI.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Qureshi WT, Zhang ZM, Chang PP, et al. Silent Myocardial Infarction and Long-Term Risk of Heart Failure: The ARIC Study. J Am Coll Cardiol. 2018. PMID: 29301615. doi:10.1016/j.jacc.2017.10.071

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。